Citation: H. Yu et R. Dinicolantonio, ALTERED NUCLEAR-PROTEIN BINDING TO THE FIRST INTRON OF THE RENIN GENEOF THE SPONTANEOUSLY HYPERTENSIVE RAT, Clinical and experimental hypertension, 20(8), 1998, pp. 817-832
Citation: F. Andersson et al., COST-EFFECTIVENESS OF FELODIPINE-METOPROLOL (LOGIMAX(R)) AND ENALAPRIL IN THE TREATMENT OF HYPERTENSION, Clinical and experimental hypertension, 20(8), 1998, pp. 833-846
Citation: Ak. Keaton et al., CAPTOPRIL TREATMENT AND ITS WITHDRAWAL PREVENTS IMPAIRMENT OF ENDOTHELIUM-DEPENDENT RESPONSES IN THE SPONTANEOUSLY HYPERTENSIVE RAT, Clinical and experimental hypertension, 20(8), 1998, pp. 847-866
Citation: A. Mazzadi et al., EFFECT OF ENALAPRIL TREATMENT ON THE HEART OF NORMAL RATS, Clinical and experimental hypertension, 20(8), 1998, pp. 867-884
Citation: Lg. Hegde et al., ALTERATIONS IN THE VASOREACTIVITY OF HYPERTENSIVE RAT AORTIC RINGS - ROLE OF NITRIC-OXIDE AND SUPEROXIDE RADICALS, Clinical and experimental hypertension, 20(8), 1998, pp. 885-901
Citation: A. Dellipizzi et A. Nasjletti, INVOLVEMENT OF NITRIC-OXIDE AND POTASSIUM CHANNELS IN THE REDUCTION OF BASAL TONE PRODUCED BY BLOCKADE OF THROMBOXANE A(2) PROSTAGLANDIN H-2 RECEPTORS IN AORTIC RINGS OF HYPERTENSIVE RATS/, Clinical and experimental hypertension, 20(8), 1998, pp. 903-916
Authors:
LOMINADZE D
JOSHUA IG
CATALFAMO JL
SCHUSCHKE DA
Citation: D. Lominadze et al., PLATELET THROMBUS FORMATION IN MICROVESSELS OF YOUNG SPONTANEOUSLY HYPERTENSIVE RATS, Clinical and experimental hypertension, 20(8), 1998, pp. 917-937
Authors:
LEBEL M
LACASSEM S
LARIVIERE R
KINGMA I
GROSE JH
Citation: M. Lebel et al., PLASMA AND BLOOD-VESSEL ENDOTHELIN-1 CONCENTRATIONS IN HYPERTENSIVE UREMIC RATS TREATED WITH ERYTHROPOIETIN, Clinical and experimental hypertension, 20(8), 1998, pp. 939-951
Authors:
MANOLIS AJ
OLYMPIOS C
SIFAKI M
SMIRNIOUDIS N
HANDANIS S
ARGIRAKIS S
KATSAROS C
GAVRAS I
GAVRAS H
Citation: Aj. Manolis et al., CHRONIC SYMPATHETIC SUPPRESSION IN THE TREATMENT OF CHRONIC CONGESTIVE-HEART-FAILURE, Clinical and experimental hypertension, 20(7), 1998, pp. 717-731
Authors:
LINZ W
ALBUS U
CRAUSE P
JUNG W
WEICHERT A
SCHOLKENS BA
SCHOLZ W
Citation: W. Linz et al., DOSE-DEPENDENT REDUCTION OF MYOCARDIAL INFARCT MASS IN RABBITS BY THENHE-1 INHIBITOR CARIPORIDE (HOE-642), Clinical and experimental hypertension, 20(7), 1998, pp. 733-749
Authors:
KOSEGAWA I
INABA M
MORITA T
AWATA T
KATAYAMA S
Citation: I. Kosegawa et al., EFFECT OF THE VASODILATORY BETA-BLOCKER, NIPRADILOL, AND CA-ANTAGONIST, BARNIDIPINE, ON INSULIN SENSITIVITY IN PATIENTS WITH ESSENTIAL-HYPERTENSION, Clinical and experimental hypertension, 20(7), 1998, pp. 751-761
Authors:
SETOGUCHI M
ONAKA U
ABE I
HASUO Y
NISHINO Y
FUJISHIMA M
Citation: M. Setoguchi et al., COMPARATIVE EFFICACIES OF A CALCIUM-ANTAGONIST AND AN ALPHA1 BLOCKER IN ELDERLY HYPERTENSIVE PATIENTS WITH STROKE, Clinical and experimental hypertension, 20(7), 1998, pp. 763-774
Citation: Rl. Webb et al., PROTECTIVE EFFECTS OF VALSARTAN AND BENAZEPRILAT IN SALT-LOADED STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS, Clinical and experimental hypertension, 20(7), 1998, pp. 775-793
Citation: Xy. Wu et al., HYPERTENSION DEVELOPMENT IN DAHL-S AND DAHL-R RATS ON HIGH-SALT LOW POTASSIUM DIET - CALCIUM, MAGNESIUM AND SYMPATHETIC NERVOUS-SYSTEM, Clinical and experimental hypertension, 20(7), 1998, pp. 795-815
Citation: Vm. Buckalew et Hc. Gonick, SUMMARY OF A SYMPOSIUM ON NATRIURETIC AND DIGITALIS-LIKE FACTORS, Clinical and experimental hypertension, 20(5-6), 1998, pp. 481-488
Citation: Bm. Anner, 2 BRAIN INHIBITORS INHIBIT RENAL NA,K-ATPASES WITHOUT RECOGNIZING THESPECIES-DEPENDENT VARIATION OF THEIR OUABAIN-SENSITIVITY, Clinical and experimental hypertension, 20(5-6), 1998, pp. 489-497
Citation: Fj. Haddy et Mb. Pamnani, ROLE OF OUABAIN-LIKE FACTORS AND NA-K-ATPASE INHIBITORS IN HYPERTENSION - SOME OLD AND RECENT FINDINGS, Clinical and experimental hypertension, 20(5-6), 1998, pp. 499-508
Citation: Mb. Pamnani et al., ROLE OF DIGITALIS-LIKE SUBSTANCE IN THE HYPERTENSION OF STREPTOZOTOCIN-INDUCED DIABETES AND SIMULATED WEIGHTLESSNESS IN RATS, Clinical and experimental hypertension, 20(5-6), 1998, pp. 509-521
Authors:
HAMLYN JM
LU ZR
MANUNTA P
LUDENS JH
KIMURA K
SHAH JR
LAREDO J
HAMILTON JP
HAMILTON MJ
HAMILTON BP
Citation: Jm. Hamlyn et al., OBSERVATIONS ON THE NATURE, BIOSYNTHESIS, SECRETION AND SIGNIFICANCE OF ENDOGENOUS OUABAIN, Clinical and experimental hypertension, 20(5-6), 1998, pp. 523-533
Citation: Jm. Sancho, A NON-OUABAIN NA K ATPASE INHIBITOR ISOLATED FROM BOVINE HYPOTHALAMUS- ITS RELATION TO HYPOTHALAMIC OUABAIN/, Clinical and experimental hypertension, 20(5-6), 1998, pp. 535-542
Citation: M. Tamura et al., NA-ATPASE INHIBITORS IN RAT URINE - ORIGINS AND PHYSIOLOGICAL SIGNIFICANCE(,K+), Clinical and experimental hypertension, 20(5-6), 1998, pp. 543-550
Citation: A. Goto et K. Yamada, PURIFICATION OF ENDOGENOUS DIGITALIS-LIKE FACTORS FROM NORMAL HUMAN URINE, Clinical and experimental hypertension, 20(5-6), 1998, pp. 551-556
Authors:
KRAMER HJ
KRAMPITZ G
BACKER A
MEYERLEHNERT H
Citation: Hj. Kramer et al., OUABAIN-LIKE FACTORS IN HUMAN URINE - IDENTIFICATION OF A NA-K-ATPASEINHIBITOR AS VANADIUM-DIASCORBATE ADDUCT, Clinical and experimental hypertension, 20(5-6), 1998, pp. 557-571
Authors:
LICHTSTEIN D
STEINITZ M
GATI I
SAMUELOV S
DEUTSCH J
ORLY J
Citation: D. Lichtstein et al., BUFODIENOLIDES AS ENDOGENOUS NA-ATPASE INHIBITORS - BIOSYNTHESIS IN BOVINE AND RAT ADRENALS(,K+), Clinical and experimental hypertension, 20(5-6), 1998, pp. 573-579
Citation: Ov. Fedorova et al., ENDOGENOUS MARINOBUFAGENIN-LIKE FACTOR IN ACUTE PLASMA-VOLUME EXPANSION, Clinical and experimental hypertension, 20(5-6), 1998, pp. 581-591